19 November 2026
Ilika plc
('Ilika', the 'Company' or the 'Group')
Trading Update & Notice of Half-Year Results
Stereax and Goliath progress
Analyst and Investor Presentations
Ilika (AIM: IKA), the UK pioneer in solid-state battery technology, provides an update on trading for the six months ended 31 October 2026 (the "Period").
Ilika expects to announce results for the Period on Thursday 21 January 2027.
Highlights:
- Continued progress in the commercialisation of Stereax, with Cirtec manufacturing several hundred M300 batteries for product validation ahead of further anticipated customer deliveries in the first half of calendar 2027
- Product revenue increased to £90,000 (H1 2025/6: £5,500), reflecting increased commercial activity through the Cirtec partnership
- Goliath 10Ah prototypes released to automotive and non-automotive partners as previously targeted, with independent testing completed by About:Energy and performance data included in The Voltt cell-selection platform
- While Ilika continues to engage with automotive partners, in parallel Ilika is addressing nearer-term Goliath opportunities in defence, marine and specialist mobility.
- Design work under the 12-month development programme with Brompton progressing to plan
- Period-end cash and cash equivalents of £6.3m (H1 2025/6: £6.9m)
Operational Update:
Stereax
Stereax batteries are miniature solid-state batteries ("SSB") for active implantable medical devices and wireless sensors.
Ilika has a ten-year manufacturing licence with Cirtec Medical LLC ("Cirtec") for the manufacture of the Stereax range of miniature batteries at Cirtec's facility in Lowell, Massachusetts, US. Following completion of manufacturing process qualification in 2025, Ilika delivered the initial batch of Stereax electrodes to Cirtec in March 2026 and has since supported Cirtec through regular electrode deliveries and process support as manufacturing yields are increased.
Cirtec has manufactured several hundred Stereax M300 batteries using electrodes supplied by Ilika. These devices are being used primarily for product validation by Cirtec and Ilika. This validation stage is distinct from the qualification of the manufacturing process previously announced. Product validation will be followed by further OEM deliveries against the existing order book, currently expected in H1 2027. During 2027, Cirtec also expects to incorporate Stereax M300 batteries into product demonstrators intended to illustrate the benefits of Stereax across its portfolio of technology platforms. These product demonstrators will support validation of Stereax by Ilika’s and Cirtec’s customers ahead of initiation of the 3-5 year process of regulatory device approval coordinated by them, ahead of broader commercial release.
Goliath
Goliath batteries are large-format SSBs designed for electric vehicles, defence and marine applications and consumer appliances.
Automotive remains an important longer-term opportunity for Goliath. The Company continues to develop its automotive battery roadmap, with the timing and scale of further investment aligned to customer feedback from the testing of its 10Ah prototypes and commitments to support the commercialisation of larger format cells.
In parallel, Ilika is pursuing commercialisation of its Goliath 10Ah technology in applications where its performance characteristics address identifiable customer requirements and where development and qualification cycles may offer a nearer-term route to market. Readily addressable opportunities include defence, marine and specialist mobility applications, supported by ongoing customer engagement and the Company’s ability to undertake small-volume manufacturing at its UK facilities.
10Ah development and independent validation
In the first half of the Period, Ilika supplied Goliath 10Ah prototypes to three US and European automotive companies, a large US-headquartered consumer electronics company, a UK defence agency and an e-bike manufacturer. The overarching 12-month, £3m grant-supported PRIMED programme, completed in September 2026, enabled Ilika to build, test and optimise the 10Ah cells, with strategic guidance from Jaguar Land Rover and Professor Paul Shearing of the University of Oxford.
To provide detailed insight to pack developers, Ilika completed independent third-party testing and verification of its Goliath cells through About:Energy. The resulting performance data are now included in The Voltt, About:Energy's cell-selection platform, providing battery-pack designers with a full suite of data and tools to assess the cells for commercial applications virtually, significantly reducing evaluation time.
Testing by some partners is still ongoing, but initial feedback from one of the automotive partners highlighted:
- A much-increased repeatability of the 10 Ah cell performance compared to the 2 Ah cells tested previously, demonstrating improvement in the quality of the Goliath manufacturing process
- Alignment of the measured cells’ performance data with the prototype’s specification sheet, demonstrating increased confidence in the manufacturing readiness level of Goliath cells
- A need to reduce self-heating and internal resistance of the cells at high power for automotive duty cycles.
Defence and marine
Following the positive results of safety testing by a UK defence agency, announced in March 2026, Ilika has continued to engage with companies supplying dual-use uncrewed vehicles, principally for land and marine applications. The combination of Goliath’s safety benefits and the possibility of sovereign supply at both cell and pack level make a compelling value proposition in this context. In September 2026, Ilika appointed Major General (Retired) Robin Anderton-Brown as a specialist defence adviser to elevate the Company’s engagement across the sector.
In October 2026, Ilika launched ORKA, a product brand for deep-sea battery systems incorporating Goliath cells. ORKA is intended to address demand for battery systems for autonomous underwater vehicles used in defence, subsea infrastructure inspection and other marine applications. The Company is progressing customer engagement and evaluation activity as it seeks to establish initial small-volume commercial opportunities.
Brompton
In April 2026, Ilika announced a 12-month joint development programme to integrate its 10Ah Goliath prototypes into battery packs for Brompton's next generation of folding e-bikes. Design work on the battery pack is progressing to plan, with the programme now focused on prototype pack manufacture and integration testing ahead of expected completion by April 2027. Successful completion could enable Ilika to address both China’s unique and highly stringent e-bike battery safety regulations, which could otherwise create a barrier for UK and European e-bike manufacturers to access Chinese markets, and Western markets where increasing scrutiny of e-bike fire safety from insurers, local authorities, and transport operators poses an additional barrier for manufacturers.
Financial Update:
The Company expects to announce revenue for the Period of £0.4m (H1 2025/6: £0.6m). Product revenue increased to £90,000 (H1 2025/6: £5,500), reflecting increased commercial activity through the Cirtec partnership. The reduction in total revenue reflects lower grant income following completion of the PRIMED programme.
EBITDA loss, excluding share-based payments, is expected to be £3.4m (H1 2025/6: loss of £3.2m). Cash and cash equivalents at the Period end were £6.3m (H1 2025/6: £6.9m). Cash expenditure during the Period was in line with the Board’s expectations and the programme of investment outlined at the time of the Company’s June 2026 fundraising.
Analyst Briefing
The management team will be hosting a hybrid analyst briefing at 9.30 am GMT on 21 January 2027. Analysts who wish to attend should contact FTI Consulting at ilika@fticonsulting.com to register.
Investor Presentation
An investor presentation will be held at 4.30 p.m. on 21 January 2027 and will be hosted through Investor Meet Company.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 20 January 2027, 9.00 am GMT, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Ilika plc via the following link: https://www.investormeetcompany.com/ilika-plc/register-investor .
Investors who already follow Ilika on the Investor Meet Company platform will automatically be invited. For more information, please contact FTI Consulting at: ilika@fticonsulting.com.
Enquiries:
Ilika plc | www.ilika.com |
Cavendish Capital Markets Limited (Nomad and Broker) | +44 (0)131 220 9772 |
FTI Consulting (Comms Adviser) | ilika@fticonsulting.com |
About Ilika plc
Ilika is a global expert in the development of solid-state battery technology for electric vehicles, medical devices, consumer appliances and defence applications. The Company’s pioneering next-generation technologies aim to provide scalable, affordable alternatives to conventional batteries, to industries which need to incorporate a smaller, lighter, and safer power source in their products.
The Company has two product lines. Its Stereax batteries are designed for powering miniature medical implants, industrial wireless sensors and Internet of Things (IoT) applications and the Goliath large format batteries are designed for EVs, consumer appliances and defence applications.
Through its licensing business model, Ilika supplies its IP portfolio to both OEMs and manufacturing partners in exchange for a license fee and future royalties.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
